Not applicableLooking for participantsNCT07191171
What this trial is testing
Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients
Who this might be right for
Dysbiosis
University Hospital, Strasbourg, France 800